申请人:——
公开号:US20040254093A1
公开(公告)日:2004-12-16
The present invention provides novel compounds of the general Formula (I) as ligands to the melanocortin receptors and/or for treatment of disorders in the melanocortin system:
1
wherein X is (CH
2
)
n
where n is 0, 1 or 2;
R
1
, R
2
, R
3
, R
4
and R
5
may be the same or different and are selected from hydrogen, halogen, alkyl having 1 to 5 carbon atoms, alkoxy having 1 to 5 carbon atoms, hydroxy, alkylsulphonyloxy, cyano, nitro, trihaloalkyl, sulpho or one of the structures given in Scheme 1; or two of R
1
, R
2
, R
3
, R
4
and R
5
may together form a methylenedioxy or ethylenedioxy moiety;
2
R
6
, R
7
, R
8
and R
9
are the same or different and are selected from hydrogen, halogen, alkyl having 1 to 5 carbon atoms, alkoxy having 1 to 5 carbon atoms, hydroxy, amines (primary, secondary or tertiary) having 0, 1 or 2 carbon atoms, cyano, nitro, trihaloalkyl, amide or sulpho, and z where shown represents the point of attachment of the residue to the phenyl or pyrrole ring;
and the pharmacologically active salts thereof.